Table 1.
Patients characteristics
| Characteristics | No (%) |
|---|---|
| Median age (years)±s.d. | 49±14 |
| Sex | |
| Male | 91 (54) |
| Female | 78 (46) |
| Hematologic disease | |
| Multiple myeloma | 40 (23) |
| Non-Hodgkin lymphoma | 37 (21) |
| AML | 33 (19) |
| Hodgkin disease | 14 (8) |
| Amyloidosis | 10 (6) |
| ALL | 9 (5) |
| Myelodysplastic syndrome | 8 (4) |
| CML | 6 (3) |
| Miscellaneous hematologic malignancies | 12 (7) |
| Non-hematologic disease | |
| Crohn | 6 (3) |
| Type of HSCT | |
| Autologous | 96 (55) |
| Allogeneic | 79 (45) |
| Related | 35 (44) |
| Unrelated | 44 (56) |
| Ablative conditioning | 15 (19) |
| Reduced intensity conditioning | 64 (81) |
| Source of stem cells | |
| Peripheral blood | 162 (92) |
| BM | 8 (5) |
| Cord blood | 3 (2) |
| Peripheral blood and BM | 2 (1) |
| Recipient CMV serostatus | |
| Positive | 128 (73) |
| Negative | 47 (27) |
Abbreviation: HSCT=hematopoietic SCT.